Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins

American Journal of Gastroenterology

Volumn 104, Issue 3, 2009, Pages 686-694

  Lembo, Anthony J ^a   Zaman, Mohammed ^a   Krueger, Robert F ^b   Tomenson, Barbara M ^c   Creed, Francis H ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IRRITABLE COLON; MALE; MENTAL DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; TWINS;

DISEASES IN TWINS; FATIGUE; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MENTAL DISORDERS; MIDDLE AGED; PAIN; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 62049083851     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.23     Document Type: Article

References (65)

1. Drossman DA, Camilleri M, Mayer EA et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
2. Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:671-82.
3. Levy RL, Olden KW, Naliboff BD et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterol 2006;130:1447-58.
4. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterol 2006;130:1480-91.
5. Whorwell PJ, McCallum M, Creed FH et al. Non-colonic features of irritable bowel syndrome. Gut 1986;27:37-40.
6. Vandvik PO, Wilhelmsen I, Ihlebaek C et al. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004;20:1195-203.
7. Vandvik PO, Lydersen S, Farup PG et al. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006;41:650-6.
8. Zaman MS, Chavez NF, Krueger R et al. Extra-intestinal symptoms in patients with irritable bowel syndrome (IBS). Gastroenterology 2001;120:A636. Ref Type: Abstract.
9. Francis CY, Duffy JN, Whorwell PJ et al. High prevalence of irritable bowel syndrome in patients attending urological outpatient departments. Dig Dis and Sci 1997;42:404-7.
10. Williams RE, Hartmann KE, Sandler RS et al. Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol 2004;104:452-8.
11. Jarrett M, Heitkemper M, Cain KC et al. Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci 2000;45:952-9.
12. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterol 2002;122:140-56.
13. Lembo A, Ameen VZ, Drossman DA et al. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol 2005;3:717-25.
14. Levy RL, Von Korff M, Whitehead WE et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastoenterol 2001;96:3122-9.
15. Creed F, Tomenson B, Guthrie E et al. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res 2008;64:613-20.
16. Whitehead WE, Palsson OS, Levy RR et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007;102:2767-76.
17. Jones KR, Palsson OS, Levy RL et al. Comorbid disorders and symptoms in Irritable Bowel Syndrome (IBS) compared to other gastroenterology patients. Gastroenterology 2001;120:A66. Ref Type: Abstract.
18. Wojczynski MK, North KE, Pedersen NL et al. Irritable bowel syndrome: a co-twin control analysis. Am J Gastroenterol 2007;102:2220-9.
19. Lembo A, Zaman M, Jones M et al. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Therapeut 2007;25:1343-50.
20. Lykken DT, Bouchard TJ Jr, McGue M et al. The Minnesota Twin Family Registry: some initial findings. Acta Geneticae Medicae et Gemellologiae 1990;39:35-70.
21. Talley NJ, Phillips SF, Melton LJ et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;11:671-4.
22. Eysenck JH, Eysenck SBG. Eysenck personality inventory. Educational and Industrial Testing Service: San Diego, 1968.
23. Zimmerman M, Mattia JI, Zimmerman M et al. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001;58:787-94.
24. Gandek B, Ware JE, Aaronson NK et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171-8.
25. Ware JE, Sherbourne CD. The MOS 36-item short form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
26. Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45:II43-6.
27. Dent J, Armstrong D, Delaney B et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004;53 (Suppl 4):iv1-24.
28. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol 2006;18:1101-9.
29. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:140-56.
30. Gillespie NA, Zhu G, Heath AC et al. The genetic aetiology of somatic distress. Psychol Med 2000;30:1051-61.
31. Kato K, Sullivan PF, Evengard B et al. A population-based twin study of functional somatic syndromes. Psychol Med; published online 26 June 2008; e-pub ahead of print.
32. Nicholl BI, Halder SL, Macfarlane GJ et al. Psychosocial risk markers for new onset irritable bowel syndrome - results of a large prospective population-based study. Pain 2008;137:147-55.
33. Hotopf M, Mayou R, Wadsworth M et al. Temporal relationships between physical symptoms and psychiatric disorder. Results from a national birth cohort. Br J Psychiatry 1998;173:255-61.
34. Alpers DH, Alpers DH. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders. J Psychosom Res 2008;64:567-72.
35. Henningsen P, Herzog W, Henningsen P et al. Irritable bowel syndrome and somatoform disorders. J Psychosom Res 2008;64:625-9.
36. Enck P, Klosterhalfen S, Zipfel S et al. Irritable bowel syndrome: a single gastrointestinal disease or a general somatoform disorder? J Psychosom Res 2008;64:561-5.
37. North CS, Downs D, Clouse RE et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004;2:787-95.
38. Chang L, Mayer EA, Johnson T et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000;84:297-307.
39. Chang L, Berman S, Mayer EA et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 2003;98:1354-61.
40. Musial F, Hauser W, Langhorst J et al. Psychophysiology of visceral pain in IBS and health. J Psychosom Res 2008;64:589-97.
41. Rapps N, Van Oudenhove L, Enck P et al. Brain imaging of visceral functions in healthy volunteers and IBS patients. J Psychosom Res 2008;64:599-604.
42. Riedl A, Schmidtmann M, Stengel A et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008;64:573-82.
43. Monga AK, Marrero JM, Stanton SL et al. Is there an irritable bladder in the irritable bowel syndrome? Br J Obstet Gynaecol 1997;104:1409-12.
44. Kennedy TM, Jones RH, Hungin AP et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998;43:70-4.
45. Kessler RC, Chiu WT, Demler O et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. [erratum appears in Arch Gen Psychiatry; 2005 Jul; 62(7):709, Note: Merikangas, Kathleen R] Arch Gen Psychiatry 2005;62:617-27.
46. Wilhelm K, Mitchell P, Slade T et al. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003;75:155-62.
47. Thompson WG, Irvine EJ, Pare P et al. Functional gastrointestinal disorders in Canada: first population based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35.
48. Boyce PM, T alley NJ, Burke C et al. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Int Med J 2006;36:28-36.
49. Minocha A, J ohnson WD, Abell TL et al. Prevalence, sociodemography, and quality of life of older vs. younger patients with irritable bowel syndrome: a population-based study. Dig Dis Sci 2006;51:446-53.
50. Badia X, Mearin F, Balboa A et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. PharmacoEconomics 2002;20:749-58.
51. Andrews EB, Eaton SC, Hollis KA et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Therapeut 2005;2:935-42.
52. Gwee KA, Wee S, Wong ML et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol 2004;9:924-31.
53. Mohammed I, Nightingale P, Trudgill NJ et al. Risk factors for gastrooesophageal reflux disease symptoms: a community study.[see comment]. Aliment Pharmacol Therapeut 2005;21:821-7.
54. Hancox RJ, Poulton R, Taylor DR et al. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Resp Res 2006;7:142.
55. Ponce J, Vegazo O, Beltran B et al. Prevalence of gastro-oesophageal reflux disease in Spain and associated factors. Aliment Pharmacol Therapeut 2006;23:175-84.
56. Locke GR III, Zinsmeister AR, Fett SL et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motility 2005;17:29-34.
57. Choung RS, Locke R, Schlek CD et al. Do Distinict Dyspepsia Sungroups Exist in the Community? Am J Gastroenterol 2007;102:1983-9.
58. Jason LA, Richman JA, Rademaker AW et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129-37.
59. Aggarwal VR, McBeth J, Zakrzewska JM et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? [see comment]. Int J Epidemiol 2006;35:468-76.
60. Kato K, Sullivan PF, Evengard B et al. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 2006;166:1649-54.
61. Naliboff BD, Balice G, Mayer EA. Psychosocial moderators of quality of life in irritable bowel syndrome. Eur J Surg Suppl 1998;583:57-9.
62. Spiegel BM, Gralnek IM, Bolus R et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004;164:1773-80.
63. Lee V, Guthrie E, Robinson A et al. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation. J Psychosom Res 2008;64:129-38.
64. Creed F, Ratcliffe J, Fernandes L et al. Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders. Br J Psychiatry 2005;186:507-15.
65. Creed F, Fernandes L, Guthrie E et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterol 2003;124:303-1